Aptose Biosciences Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Right-of-use Assets (Tables)

9 Months Ended

Sep. 30, 2022

	Nine months ended September 30, 2022			Year ended December 31, 2021

Right-of-use assets, beginning of period	$	1,860		$	1,848
Additions to right-of-use assets		91			12
Right-of-use assets, end of period		1,951			1,860
Accumulated amortization		(1,731	)		(1,395	)
Right-of use assets, NBV	$	220		$	465